North East Local Health Integration Network

BD² ANNOUNCES RESEARCH AND CLINICAL NETWORK TO ADVANCE TREATMENT FOR BIPOLAR DISORDER

Retrieved on: 
Wednesday, September 27, 2023
Partnership, Mayo Clinic, University, University of Michigan, Schizophrenia, Cone Health Women's Hospital, Cardiovascular disease, Research, Harvard Medical School, Attention, Bangladesh Technical Education Board, Doctor of Philosophy, Bipolar disorder, North East Local Health Integration Network, Discovery, Johns Hopkins University, MD, Patient, Milken Institute, Knowledge, Diagnosis, Hospital, University of California, Los Angeles, Health, Disease, Research fellow, Pharmaceutical industry, Psychology, Brigham, Psychiatry

WASHINGTON, Sept. 27, 2023 /PRNewswire/ -- BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder today announced the first six institutions that will launch the groundbreaking BD² Integrated Network. Brigham and Women's Hospital-McLean Hospital, University of California Los Angeles, Johns Hopkins University, Mayo Clinic, University of Michigan, and UTHealth Houston together comprise the first sites that will work in partnership with clinicians, researchers, and people living with bipolar disorder to expand knowledge of bipolar disorder while accelerating the translation of that knowledge into clinical care. The BD² Integrated Network integrates clinical, behavioral, and biological data to gain new insight into bipolar disorder and accelerate improved treatment. Over the next five years, it will engage 4,000 people living with bipolar disorder as part of a longitudinal cohort study.

Key Points: 
  • The BD² Integrated Network integrates clinical, behavioral, and biological data to gain new insight into bipolar disorder and accelerate improved treatment.
  • Over the next five years, it will engage 4,000 people living with bipolar disorder as part of a longitudinal cohort study.
  • "For too long, there have been limited breakthroughs in the study and treatment of bipolar disorder," said Cara Altimus, PhD, managing director for BD² and senior director at the Milken Institute.
  • "Current understanding of the mechanisms of bipolar disorder are inadequate to meet the needs of individuals living with bipolar disorder today," said Mark Frye, MD, BD² Integrated Network scientific director.

Global Platform Launches to Transform Bipolar Disorder Research and Care

Retrieved on: 
Monday, September 12, 2022
Science, Milken Institute, Health, Bipolar disorder, Parkinson's disease, Biomedical Research, Hospital, ASAP, Knowledge, North East Local Health Integration Network, Google, Cognition, Bangladesh Technical Education Board, Massachusetts General Hospital, BD2, Foundation, Genotype, Mental health, Investment, Neurological disorder, List of acquisitions by Cisco Systems, CEO, Genetics, Leadership, Doctor of Philosophy, Diagnosis, Method, Thought disorder, Research, Overalls, David Baszucki, Multimedia, Environmental health, Milken, Disease, Pharmaceutical industry, Management, Roblox

WASHINGTON, Sept. 12, 2022 /PRNewswire/ -- Today, three family philanthropies joined with the Milken Institute to commit $150 million to launch BD2: Breakthrough Discoveries for thriving with Bipolar Disorder.

Key Points: 
  • While funding for mental health has increased overall, federal funding for research related exclusively to bipolar disorder has decreased by 50% over the past 10 years .
  • Kent Dauten and his wife, Liz, have supported bipolar disorder research extensively after two of their four children were diagnosed as teenagers.
  • "Together, we will accelerate discoveries for bipolar disorder and demonstrate that our approach to collaborative funding and integrated research is a new model for biomedical research."
  • The study design and infrastructure prioritize rapid implementation of research findings to improve treatment for all those living with bipolar disorder."